TOBAM’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$562K Buy
1,259
+105
+9% +$49K 0.15% 139
2025
Q4
$523K Buy
+1,154
New +$497K 0.13% 146
2025
Q3
Sell
-3
Closed -$1K 280
2025
Q2
$1K Hold
3
﹤0.01% 253
2025
Q1
$1K Sell
3
-361
-99% -$168K ﹤0.01% 251
2024
Q4
$147K Sell
364
-117
-24% -$54.2K 0.04% 180
2024
Q3
$224K Sell
481
-144
-23% -$69.2K 0.04% 176
2024
Q2
$293K Sell
625
-1,358
-68% -$589K 0.05% 156
2024
Q1
$829K Sell
1,983
-88
-4% -$37.2K 0.07% 109
2023
Q4
$843K Sell
2,071
-826
-29% -$305K 0.07% 94
2023
Q3
$1.01M Sell
2,897
-324
-10% -$113K 0.08% 95
2023
Q2
$1.13M Hold
3,221
0.09% 99
2023
Q1
$1.01M Hold
3,221
0.07% 111
2022
Q4
$930K Sell
3,221
-138
-4% -$42.1K 0.06% 109
2022
Q3
$973K Sell
3,359
-13,701
-80% -$3.94M 0.07% 117
2022
Q2
$4.81M Sell
17,060
-16,067
-49% -$4.3M 0.3% 67
2022
Q1
$8.64M Buy
33,127
+27,114
+451% +$6.43M 0.43% 64
2021
Q4
$1.32M Buy
6,013
+381
+7% +$74.1K 0.06% 114
2021
Q3
$1.02M Buy
5,632
+4,739
+531% +$925K 0.04% 118
2021
Q2
$180K Hold
893
0.01% 207
2021
Q1
$192K Hold
893
0.01% 192
2020
Q4
$211K Hold
893
0.01% 187
2020
Q3
$243K Buy
+893
New +$246K 0.01% 156
2015
Q3
Sell
-343,144
Closed -$42.4M 148
2015
Q2
$42.4M Sell
343,144
-132,327
-28% -$16.7M 1.55% 24
2015
Q1
$56.1M Buy
475,471
+90,644
+24% +$10.9M 1.71% 25
2014
Q4
$45.7M Sell
384,827
-130,648
-25% -$14.7M 1.51% 25
2014
Q3
$57.9M Buy
515,475
+408,674
+383% +$38.9M 1.64% 23
2014
Q2
$10.1M Sell
106,801
-286,823
-73% -$20.1M 0.45% 62
2014
Q1
$27.8M Sell
393,624
-32,301
-8% -$2.56M 1.39% 29
2013
Q4
$31.6M Buy
425,925
+107,001
+34% +$7.45M 1.62% 23
2013
Q3
$24.2M Buy
318,924
+130,480
+69% +$10.4M 1.35% 31
2013
Q2
$15.1M Buy
+188,444
New +$13.9M 0.99% 37

Other funds holding VRTX